Commercial multiple electrode lead technology for cardiac disease

Projektinformationen

AXONE

ID Finanzhilfevereinbarung: 737817

DOI 10.3030/737817

Projekt abgeschlossen

EK-Unterschriftsdatum 20 Januar 2017

Startdatum 1 Januar 2017

Enddatum 31 Dezember 2020

Finanziert unter

• Horizon 2020 Framework Programme

Gesamtkosten € 3 513 187,50

EU-Beitrag € 2 694 187,50

Koordiniert durch

SORIN CRM SAS
France

Leistungen

Documents, reports (5)

Summary of all dissemination and communication activities performed
Intermediate chronic clinical study report

Intermediate clinical report with 3 months follow up

Preclinical safety performance report

Report describing the long term preclinical study (3-6months) to demonstrate product safety on animal model

Final acute clinical study report

Report including all the results of the clinical study

AXONE benefit over standard CRT report

Preclinical report describing the potential benefit of Axone in comparision with current device on animal model